Abstract

The aim of this study was to reduce antimicrobial use (AMU) on dairy farms that implemented evidence-based management strategies. The study not only examined whether these strategies led to a reduction in AMU in practice, but also examined the influence of the level of their implementation on AMU. For data analysis, practice software recordings of the farm veterinarians were used. The AMU data of 50 farms with prevention strategies applied (intervention group, IG) over 3 years (2017–2019) and of 74 farms without prevention strategies (control group, CG) over 2 years (2018–2019) were analyzed. Project participation was supported with 500 Swiss francs (~545 USD) per farmer per year. The AMU was compared between the IG and CG using the treatment incidence. In December 2017/January 2018, the farmers of the IG had chosen at least one of the proposed 17 prevention strategies from one of three sectors, i.e., udder health, uterine health and/or replacement calf health. The prevention strategies, were developed in a standard operating procedure protocol and were discussed in detail with the farmers before the implementation. Forty-eight farms chose at least one udder strategy, 10 farms at least one uterine strategy and 37 farms at least one calf strategy. By choosing an udder health strategy or a uterine health strategy, the corresponding systemically administered AMU could be significantly reduced (p < 0.04) in the IG compared with the CG. In addition, udder strategies that were well-implemented led to a significant reduction (p = 0.05) of intramammary “highest priority critically important antimicrobials (HPCIA)” (quinolones, cephalosporins 3rd and higher generation, macrolides and ketolides, glycopeptides, and polymyxins). The level of implementation was significantly lower in 2019 compared to 2018 (p < 0.05, Fisher's exact test). No significant reduction in AMU could be achieved for the calf sector. A reduction of AMU in dairy farms is possible by implementing evidence-based management-related prevention strategies. The level of implementation has only an influence on the consumption of HPCIA. The reduction of AMU in practice by means of evidence-based measures requires supportive human resources instead of financial support, because financial support for farmers seems not to motivate them sufficiently.

Highlights

  • The development of antimicrobial resistances in bacteria leads to major problems in both human and veterinary medicine

  • In the study presented here, we investigated for the first time the implementation level of management changes as a factor influencing AM reduction on Swiss dairy farms

  • This study investigated the effect of evidence-based prevention strategies on antimicrobial use (AMU) in three health sectors, udder, uterus and replacement calves

Read more

Summary

Introduction

The development of antimicrobial resistances in bacteria leads to major problems in both human and veterinary medicine. Evidence-based means adherence to a procedure, in this case the treatment with antimicrobials (AMs), which is based on the best and most recent scientific knowledge. The sales of AMs in veterinary medicine in Switzerland decreased from 76 mg/PCU (population correction unit: 1 PCU = 1 kg farm animal) in 2009 to 38 mg/PCU in 2019 [1]. This reduction was mainly due to lower sales of drug premixes. Switzerland ranked first for highest intramammary AM drug user and second for intrauterine AM-containing preparations [2]. Due to the fact that these two categories are used almost exclusively for cows and there are many more dairy cows [522,723 in 2018 [3]] than female, adult suckler cows [14,034 cows in 2018 [4]] in Switzerland, it can be assumed that this consumption is mainly attributable to dairy cattle

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call